ThermoGenesis makes orthopedic partnership: 3 notes

Written by Mackenzie Garrity | February 01, 2019 | Print  |

ThermoGenesis Corp. entered into a supply agreement with Los Angeles-based Orthohealing Center Management.

Three notes:

1. Per the agreement, OCM's network of physicians will be able to use the ThermoGenesis PXP system to prepare a precise cell concentrate from autologous bone marrow in their office labs.

2. The PXP system is a lab equipment that automates the harvest of a precise volume of cell concentrate from bone marrow aspirate in a sterile process at the point of care. PXP can generate bone marrow monocular cells and platelets in less than 20 minutes.

3. Processing data is captured using ThermoGenesis' proprietary DataTrak software to assist with optimal manufacturing monitoring and reporting information.

More articles on biologics:
CDC investigates contaminated stem cell products: 5 things to know
Global spine biologics market to hit $2.7B by 2024 — 18 key players
U of Missouri to release biojoint records amid allegations of false marketing: 5 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months